サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1697903

臨床業務・開発の世界市場：市場規模・シェア・動向、業界分析 (相別・サービスの種類別・適応症別・最終用途別・地域別)、将来予測 (2025年～2034年)

Clinical Operations and Development Market Size, Share, Trends, Industry Analysis Report: By Phase, Service Type, Indication, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 155 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
臨床業務・開発の世界市場：市場規模・シェア・動向、業界分析 (相別・サービスの種類別・適応症別・最終用途別・地域別)、将来予測 (2025年～2034年)
出版日: 2025年03月01日
発行: Polaris Market Research
ページ情報: 英文 155 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、臨床業務・開発の市場規模は2034年までに1,762億9,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

臨床業務・開発市場は、新薬や治療法の安全性と有効性を評価するための臨床試験の計画、実施、管理を包含します。この市場は製薬業界やバイオテクノロジー業界において重要な役割を担っており、医薬品開発プロセスを加速させながら規制基準を満たすことを保証しています。慢性疾患の増加、臨床試験の複雑化、個別化医療の進展が、臨床業務・開発市場の需要を牽引しています。

製薬業界における研究開発活動の急増により、臨床業務・開発サービスに対する需要は着実に高まっています。がん、神経疾患、希少疾患の増加により、臨床試験の量が増加しています。例えば、がん領域の臨床試験では、免疫療法や標的治療を含むがん治療の複雑性から、広範な安全性評価が必要となります。このようなサービスに対する需要は、FDAやEMAなどの機関が課す厳しい規制要件によって強化されており、患者の安全性とデータの完全性を確保するために厳格な臨床試験プロトコルが義務付けられています。

臨床業務・開発市場は、分散型臨床試験（DCT）やAIを活用した調査手法の導入により、大きな変貌を遂げています。これらの進歩により、特に中枢神経系（CNS）疾患など課題の多い治療領域では、患者の採用と維持が改善されています。欧州は、多様な患者集団と強力な医療インフラを提供し、臨床業務・開発の主な地域であることに変わりはないです。同地域の緩やかな人口成長と研究開発に対する政府の支援は、臨床事業・開発市場の拡大に有利な機会をもたらしています。臨床業務の継続的な進化は、医薬品開発の将来を形作る上で重要な役割を果たします。

臨床業務・開発市場：分析概要

相別（フェーズ別）では、大規模臨床試験、規制要件、AI主導の最適化の出現、RWEの統合が臨床試験の効率化と市場の発展を促進し、第III相セグメントが2024年の臨床業務・開発市場シェアを独占しました。

サービスの種類別では、実験室サービス・バイオ分析試験の分野が予測期間中に最も高いCAGRを記録すると予測され、これは高度な分析技術、バイオマーカー分析、個別化医療の採用、医薬品開発における規制遵守が原動力となっています。

北米は、製薬投資の増加、先進的な試験技術、規制支援、AI統合、Elligo Health ResearchのAI主導型データコネクトプラットフォームなどのイノベーションにより、臨床業務・開発市場の収益シェアをリードしています。

世界の主要企業は、ClinChoice、Thermo Fisher Scientific Inc.（PPD Inc.）、IQVIA、Charles River Laboratories、Syneos Health、Eli Lilly and Company、Pfizer Inc.、Novo Nordisk A/S、Parexel International（MA）Corporation、Caidyaなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 世界の臨床業務・開発市場の洞察

  • 臨床業務・開発：業界スナップショット
  • バリューチェーン分析
    • 臨床業務・開発の市場力学
    • 促進要因と機会
      • 世界的に慢性疾患の有病率が増加
      • 新興国における医療インフラの拡大
    • 抑制要因と課題
      • 規制コンプライアンス
  • ポーターのファイブフォース分析
    • サプライヤーの交渉力 (低～中)
    • 新規参入企業の脅威 (中)
    • バイヤーの交渉力 (中)
    • 代替製品の脅威 (中～高)
    • 企業間競争 (高)
  • PESTLE分析

第5章 臨床業務・開発市場の評価：相別

  • イントロダクション
  • 第I相
  • 第II相
  • 第III相
  • 第IV相

第6章 臨床業務・開発市場の評価：サービスの種類別

  • イントロダクション
  • 実験室サービス・バイオ分析試験：BA/BE
  • データ管理・生物統計サービス
  • サイト管理・監視サービス
  • メディカルライティング＆出版サービス
  • 患者募集・維持サービス
  • その他

第7章 臨床業務・開発市場の評価：適応症別

  • イントロダクション
  • 腫瘍学
  • 中枢神経系（CNS）疾患
  • 心血管疾患（CVD）
  • 代謝/内分泌
  • 呼吸器
  • 感染症
  • その他

第8章 臨床業務・開発市場の評価：地域別

  • イントロダクション
  • 北米の臨床業務・開発市場
    • 国別
    • 相別
    • サービスの種類別
    • 適応症別
    • 米国の臨床業務・開発市場
    • カナダの臨床業務・開発市場
  • 欧州の臨床業務・開発市場
    • 国別
    • 相別
    • サービスの種類別
    • 適応症別
    • 英国の臨床業務・開発市場
    • フランスの臨床業務・開発市場
    • ドイツの臨床業務・開発市場
    • イタリアの臨床業務・開発市場
    • スペインの臨床業務・開発市場
    • オランダの臨床業務・開発市場
    • ロシアの臨床業務・開発市場
    • その他欧州の臨床業務・開発市場
  • アジア太平洋地域の臨床業務・開発市場
    • 国別
    • 相別
    • サービスの種類別
    • 適応症別
    • 中国の臨床業務・開発市場
    • 日本の臨床業務・開発市場
    • 韓国の臨床業務・開発市場
    • インドの臨床業務・開発市場
    • オーストラリアの臨床業務・開発市場
    • その他アジア太平洋地域の臨床業務・開発市場
  • ラテンアメリカの臨床業務・開発市場
    • 国別
    • 相別
    • サービスの種類別
    • 適応症別
    • ブラジルの臨床業務・開発市場
    • メキシコの臨床業務・開発市場
    • アルゼンチンの臨床業務・開発市場
    • その他ラテンアメリカの臨床業務・開発市場
  • 中東・アフリカの臨床業務・開発市場
    • 国別
    • 相別
    • サービスの種類別
    • 適応症別
    • UAEの臨床業務・開発市場
    • イスラエルの臨床業務・開発市場
    • サウジアラビアの臨床業務・開発市場
    • 南アフリカの臨床業務・開発市場
    • その他中東とアフリカの臨床業務・開発市場

第9章 競合情勢

  • 主要市場プレーヤー：分類
  • 戦略的枠組み
  • ベンダー情勢
  • 戦略の分類
    • 立ち上げ/拡大/投資
    • パートナーシップ/コラボレーション/買収

第10章 企業プロファイル

  • ClinChoice
  • Thermo Fisher Scientific Inc.（PPD Inc.）
  • IQVIA
  • Charles River Laboratories
  • Syneos Health
  • Eli Lilly and Company
  • Pfizer Inc.
  • Novo Nordisk A/S
  • Parexel International（MA）Corporation
  • Caidya
図表

List of Tables

  • Table 1 Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 2 Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 3 Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 4 Clinical Operations and Development Market Assessment, By Geography, 2021 - 2034 (USD Billion)
  • Table 5 North America Clinical Operations and Development Market, By Country, 2021 - 2034 (USD Billion)
  • Table 6 North America Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 7 North America Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 8 North America Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 9 US Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 10 US Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 11 US Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 12 Canada Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 13 Canada Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 14 Canada Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 15 Europe Clinical Operations and Development Market, By Country, 2021 - 2034 (USD Billion)
  • Table 16 Europe Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 17 Europe Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 18 Europe Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 19 UK Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 20 UK Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 21 UK Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 22 France Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 23 France Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 24 France Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 25 Germany Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 26 Germany Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 27 Germany Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 28 Italy Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 29 Italy Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 30 Italy Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 31 Spain Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 32 Spain Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 33 Spain Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 34 Netherlands Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 35 Netherlands Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 36 Netherlands Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 37 Russia Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 38 Russia Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 39 Russia Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 40 Rest of Europe Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 41 Rest of Europe Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 42 Rest of Europe Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 43 Asia Pacific Clinical Operations and Development Market, By Country, 2021 - 2034 (USD Billion)
  • Table 44 Asia Pacific Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 45 Asia Pacific Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 46 Asia Pacific Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 47 China Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 48 China Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 49 China Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 50 Japan Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 51 Japan Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 52 Japan Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 53 South Korea Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 54 South Korea Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 55 South Korea Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 56 India Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 57 India Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 58 India Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 59 Australia Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 60 Australia Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 61 Australia Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 62 Rest of Asia Pacific Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 63 Rest of Asia Pacific Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 64 Rest of Asia Pacific Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 65 Latin America Clinical Operations and Development Market, By Country, 2021 - 2034 (USD Billion)
  • Table 66 Latin America Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 67 Latin America Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 68 Latin America Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 69 Brazil Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 70 Brazil Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 71 Brazil Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 72 Mexico Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 73 Mexico Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 74 Mexico Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 75 Argentina Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 76 Argentina Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 77 Argentina Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 78 Rest of Latin America Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 79 Rest of Latin America Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 80 Rest of Latin America Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 81 Middle East and Africa Clinical Operations and Development Market, By Country, 2021 - 2034 (USD Billion)
  • Table 82 Middle East and Africa Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 83 Middle East and Africa Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 84 Middle East and Africa Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 85 UAE Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 86 UAE Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 87 UAE Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 88 Israel Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 89 Israel Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 90 Israel Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 91 Saudi Arabia Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 92 Saudi Arabia Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 93 Saudi Arabia Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 94 South Africa Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 95 South Africa Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 96 South Africa Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)
  • Table 97 Rest of Middle East & Africa Clinical Operations and Development Market, By Phase, 2021 - 2034 (USD Billion)
  • Table 98 Rest of Middle East & Africa Clinical Operations and Development Market, By Service Type, 2021 - 2034 (USD Billion)
  • Table 99 Rest of Middle East & Africa Clinical Operations and Development Market, By Indication, 2021 - 2034 (USD Billion)

List of Figures

  • Figure 1. Information Procurement
  • Figure 2. Primary Research Pattern
  • Figure 3. Primary research process
  • Figure 4. Market research approaches - Bottom-Up Approach
  • Figure 5. Market research approaches - Top-Down Approach
  • Figure 6. Market research approaches - Combined Approach
  • Figure 7. Executive Summary
  • Figure 8. Market by Region, 2024 (USD Billion)
  • Figure 9. Clinical Operations and Development Market, 2021 - 2034 (USD Billion)
  • Figure 10. Value Chain Analysis
  • Figure 11. Porter's Five Forces
  • Figure 12. PESTLE Analysis
  • Figure 13. Market, By Phase
  • Figure 14. Clinical Operations and Development Market, By Phase, 2024 & 2034 (USD Billion)
  • Figure 15. Clinical Operations and Development Market, By Phase I, 2021 - 2034 (USD Billion)
  • Figure 16. Clinical Operations and Development Market, By Phase II, 2021 - 2034 (USD Billion)
  • Figure 17. Clinical Operations and Development Market, By Phase III, 2021 - 2034 (USD Billion)
  • Figure 18. Clinical Operations and Development Market, By Phase IV, 2021 - 2034 (USD Billion)
  • Figure 19. Market, By Service Type
  • Figure 20. Clinical Operations and Development Market, By Service Type, 2024 & 2034 (USD Billion)
  • Figure 21. Clinical Operations and Development Market, By Laboratory Services & Bioanalytical Testing - BA/BE, 2021 - 2034 (USD Billion)
  • Figure 22. Clinical Operations and Development Market, By Data Management & Biostatistics Services, 2021 - 2034 (USD Billion)
  • Figure 23. Clinical Operations and Development Market, By Site Management & Monitoring Services, 2021 - 2034 (USD Billion)
  • Figure 24. Clinical Operations and Development Market, By Medical Writing & Publishing Services, 2021 - 2034 (USD Billion)
  • Figure 25. Clinical Operations and Development Market, By Patient Recruitment & Retention Services, 2021 - 2034 (USD Billion)
  • Figure 26. Clinical Operations and Development Market, By Others, 2021 - 2034 (USD Billion)
  • Figure 27. Market, By Indication
  • Figure 28. Clinical Operations and Development Market, By Indication, 2024 & 2034 (USD Billion)
  • Figure 29. Clinical Operations and Development Market, By Oncology, 2021 - 2034 (USD Billion)
  • Figure 30. Clinical Operations and Development Market, By Central Nervous System (CNS) Disorders, 2021 - 2034 (USD Billion)
  • Figure 31. Clinical Operations and Development Market, By Cardiovascular Diseases (CVD), 2021 - 2034 (USD Billion)
  • Figure 32. Clinical Operations and Development Market, By Metabolic/Endocrine, 2021 - 2034 (USD Billion)
  • Figure 33. Clinical Operations and Development Market, By Respiratory, 2021 - 2034 (USD Billion)
  • Figure 34. Clinical Operations and Development Market, By Infectious Diseases, 2021 - 2034 (USD Billion)
  • Figure 35. Clinical Operations and Development Market, By Others, 2021 - 2034 (USD Billion)
  • Figure 36. Clinical Operations and Development Market Assessment, By Geography, 2024 & 2034 (USD Billion)
目次
Product Code: PM5388

The clinical operations and development market size is expected to reach USD 176.29 billion by 2034, according to a new study by Polaris Market Research. The report "Clinical Operations and Development Market Size, Share, Trends, Industry Analysis Report: By Phase (Phase I, Phase II, Phase III, and Phase IV), Service Type, Indication, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The clinical operations and development market encompasses the planning, execution, and management of clinical trials to evaluate the safety and efficacy of new drugs and medical treatments. This market plays a vital role in the pharmaceutical and biotechnology industries, ensuring that regulatory standards are met while accelerating the drug development process. The increasing prevalence of chronic diseases, growing complexity of clinical trials, and advancements in personalized medicine drive the clinical operations and development market demand.

The demand for clinical operations and development services is steadily rising due to the surge in research and development activities within the pharmaceutical sector. The increasing prevalence of cancer, neurological disorders, and rare diseases has led to a higher volume of clinical trials. For instance, oncology clinical trials require extensive safety evaluations due to the complexity of cancer therapies, including immunotherapies and targeted treatments. The demand for these services is reinforced by stringent regulatory requirements imposed by agencies such as the FDA and EMA, which mandate rigorous trial protocols to ensure patient safety and data integrity.

The clinical operations and development market has witnessed significant transformation with the adoption of decentralized clinical trials (DCTs) and AI-driven research methodologies. These advancements have improved patient recruitment and retention, particularly in challenging therapeutic areas such as central nervous system (CNS) disorders. Europe remains a key region for clinical operations and developments, offering a diverse patient population and strong healthcare infrastructure. The gradual population growth in the region, coupled with government support for research initiatives, presents lucrative opportunities for clinical operations and development market expansion. The continued evolution of clinical operations plays a crucial role in shaping the future of drug development.

Clinical Operations and Development Market Report Highlights

By phase, the phase III segment dominated the clinical operations and development market share in 2024, driven by large-scale trials, regulatory requirements, emergence of AI-driven optimization, and real-world evidence integration, enhancing trial efficiency and market growth.

By service type, the laboratory services and bioanalytical testing segment is projected to register the highest CAGR during the forecast period, driven by the adoption of advanced analytical techniques, biomarker analysis, and personalized medicine, as well as regulatory compliance in drug development.

North America leads the clinical operations and development market revenue share, driven by rising pharmaceutical investments, advanced trial technologies, regulatory support, AI integration, and innovations such as Elligo Health Research's AI-driven Data Connect platform.

A few global key market players are ClinChoice, Thermo Fisher Scientific Inc. (PPD Inc.), IQVIA, Charles River Laboratories, Syneos Health, Eli Lilly and Company, Pfizer Inc., Novo Nordisk A/S, Parexel International (MA) Corporation, and Caidya.

Polaris Market Research has segmented the clinical operations and development market report on the basis of phase, service type, indication, and region:

By Phase Outlook (Revenue, USD Billion, 2020-2034)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Service Type Outlook (Revenue, USD Billion, 2020-2034)

  • Laboratory Services & Bioanalytical Testing
  • Data Management & Biostatistics Services
  • Site Management & Monitoring Services
  • Medical Writing & Publishing Services
  • Patient Recruitment & Retention Services
  • Others

By Indication Outlook (Revenue, USD Billion, 2020-2034)

  • Oncology
  • Central Nervous System (CNS) Disorders
  • Cardiovascular Disease (CVD)
  • Metabolic/Endocrine Diseases
  • Respiratory Diseases
  • Infectious Diseases
  • Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

Chapter 1. Introduction

  • 1.1 Report Description
    • 1.1.1 Objective of the Study
    • 1.1.2 Market Scope
    • 1.1.3 Assumptions
  • 1.2 Stakeholders

Chapter 2. Research Methodology

  • 2.1 Research Methodology
  • 2.2 Research Scope and Assumptions
  • 2.3 Information Procurement
    • 2.3.1 Purchased Database
    • 2.3.2 Internal Database
    • 2.3.3 Secondary Sources
    • 2.3.4 Third Party Perspective
    • 2.3.5 Primary Research
  • 2.4 Information Analysis
    • 2.4.1 Data Analysis Models
  • 2.5 Market Formulation and Data Visualization
  • 2.6 Data Validation and Publishing (Secondary Sources)

Chapter 3. Executive Summary

Chapter 4. Market Insights

  • 4.1 Clinical Operations and Development - Industry snapshot
  • 4.2 Clinical Operations and Development Market - Value Chain Analysis
    • 4.2.1 Clinical Operations and Development Market Dynamics
    • 4.2.2 Drivers and Opportunities
      • 4.2.2.1 Growing Prevalence of Chronic Diseases Globally
      • 4.2.2.2 Expanding Healthcare Infrastructure in Emerging Economies
    • 4.2.3 Restraints and Challenges
      • 4.2.3.1 Regulatory Compliance
  • 4.3 Clinical Operations and Development Market - Porter's Five Forces
    • 4.3.1 Threat of Substitutes: Low to Moderate
    • 4.3.2 Threat of New Entrants: Moderate
    • 4.3.3 Bargaining power of buyers: Moderate
    • 4.3.4 Bargaining power of suppliers: Moderate to High
    • 4.3.5 Competitive Rivalry: High
  • 4.4 Clinical Operations and Development Market - PESTLE Analysis

Chapter 5. Clinical Operations and Development Market Assessment, By Phase

  • 5.1 Introduction
  • 5.2 Phase I
  • 5.3 Phase II
  • 5.4 Phase III
  • 5.5 Phase IV

Chapter 6. Clinical Operations and Development Market Assessment, By Service Type

  • 6.1 Introduction
  • 6.2 Laboratory Services & Bioanalytical Testing - BA/BE
  • 6.3 Data Management & Biostatistics Services
  • 6.4 Site Management & Monitoring Services
  • 6.5 Medical Writing & Publishing Services
  • 6.6 Patient Recruitment & Retention Services
  • 6.7 Others

Chapter 7. Clinical Operations and Development Market Assessment, By Indication

  • 7.1 Introduction
  • 7.2 Oncology
  • 7.3 Central Nervous System (CNS) Disorders
  • 7.4 Cardiovascular Diseases (CVD)
  • 7.5 Metabolic/Endocrine
  • 7.6 Respiratory
  • 7.7 Infectious Diseases
  • 7.8 Others

Chapter 8. Clinical Operations and Development Market Assessment, By Region

  • 8.1 Introduction
  • 8.2 North America Clinical Operations and Development Market
    • 8.2.1 North America Clinical Operations and Development Market, By Country
    • 8.2.2 North America Clinical Operations and Development Market, By Phase
    • 8.2.3 North America Clinical Operations and Development Market, By Service Type
    • 8.2.4 North America Clinical Operations and Development Market, By Indication
    • 8.2.5 US Clinical Operations and Development Market
      • 8.2.5.1 US Clinical Operations and Development Market, By Phase
      • 8.2.5.2 US Clinical Operations and Development Market, By Service Type
      • 8.2.5.3 US Clinical Operations and Development Market, By Indication
    • 8.2.6 Canada Clinical Operations and Development Market
      • 8.2.6.1 Canada Clinical Operations and Development Market, By Phase
      • 8.2.6.2 Canada Clinical Operations and Development Market, By Service Type
      • 8.2.6.3 Canada Clinical Operations and Development Market, By Indication
  • 8.3 Europe Clinical Operations and Development Market
    • 8.3.1 Europe Clinical Operations and Development Market, By Country
    • 8.3.2 Europe Clinical Operations and Development Market, By Phase
    • 8.3.3 Europe Clinical Operations and Development Market, By Service Type
    • 8.3.4 Europe Clinical Operations and Development Market, By Indication
    • 8.3.5 UK Clinical Operations and Development Market
      • 8.3.5.1 UK Clinical Operations and Development Market, By Phase
      • 8.3.5.2 UK Clinical Operations and Development Market, By Service Type
      • 8.3.5.3 UK Clinical Operations and Development Market, By Indication
    • 8.3.6 France Clinical Operations and Development Market
      • 8.3.6.1 France Clinical Operations and Development Market, By Phase
      • 8.3.6.2 France Clinical Operations and Development Market, By Service Type
      • 8.3.6.3 France Clinical Operations and Development Market, By Indication
    • 8.3.7 Germany Clinical Operations and Development Market
      • 8.3.7.1 Germany Clinical Operations and Development Market, By Phase
      • 8.3.7.2 Germany Clinical Operations and Development Market, By Service Type
      • 8.3.7.3 Germany Clinical Operations and Development Market, By Indication
    • 8.3.8 Italy Clinical Operations and Development Market
      • 8.3.8.1 Italy Clinical Operations and Development Market, By Phase
      • 8.3.8.2 Italy Clinical Operations and Development Market, By Service Type
      • 8.3.8.3 Italy Clinical Operations and Development Market, By Indication
    • 8.3.9 Spain Clinical Operations and Development Market
      • 8.3.9.1 Spain Clinical Operations and Development Market, By Phase
      • 8.3.9.2 Spain Clinical Operations and Development Market, By Service Type
      • 8.3.9.3 Spain Clinical Operations and Development Market, By Indication
    • 8.3.10 Netherlands Clinical Operations and Development Market
      • 8.3.10.1 Netherlands Clinical Operations and Development Market, By Phase
      • 8.3.10.2 Netherlands Clinical Operations and Development Market, By Service Type
      • 8.3.10.3 Netherlands Clinical Operations and Development Market, By Indication
    • 8.3.11 Russia Clinical Operations and Development Market
      • 8.3.11.1 Russia Clinical Operations and Development Market, By Phase
      • 8.3.11.2 Russia Clinical Operations and Development Market, By Service Type
      • 8.3.11.3 Russia Clinical Operations and Development Market, By Indication
    • 8.3.12 Rest of Europe Clinical Operations and Development Market
      • 8.3.12.1 Rest of Europe Clinical Operations and Development Market, By Phase
      • 8.3.12.2 Rest of Europe Clinical Operations and Development Market, By Service Type
      • 8.3.12.3 Rest of Europe Clinical Operations and Development Market, By Indication
  • 8.4 Asia Pacific Clinical Operations and Development Market
    • 8.4.1 Asia Pacific Clinical Operations and Development Market, By Country
    • 8.4.2 Asia Pacific Clinical Operations and Development Market, By Phase
    • 8.4.3 Asia Pacific Clinical Operations and Development Market, By Service Type
    • 8.4.4 Asia Pacific Clinical Operations and Development Market, By Indication
    • 8.4.5 China Clinical Operations and Development Market
      • 8.4.5.1 China Clinical Operations and Development Market, By Phase
      • 8.4.5.2 China Clinical Operations and Development Market, By Service Type
      • 8.4.5.3 China Clinical Operations and Development Market, By Indication
    • 8.4.6 Japan Clinical Operations and Development Market
      • 8.4.6.1 Japan Clinical Operations and Development Market, By Phase
      • 8.4.6.2 Japan Clinical Operations and Development Market, By Service Type
      • 8.4.6.3 Japan Clinical Operations and Development Market, By Indication
    • 8.4.7 South Korea Clinical Operations and Development Market
      • 8.4.7.1 South Korea Clinical Operations and Development Market, By Phase
      • 8.4.7.2 South Korea Clinical Operations and Development Market, By Service Type
      • 8.4.7.3 South Korea Clinical Operations and Development Market, By Indication
    • 8.4.8 India Clinical Operations and Development Market
      • 8.4.8.1 India Clinical Operations and Development Market, By Phase
      • 8.4.8.2 India Clinical Operations and Development Market, By Service Type
      • 8.4.8.3 India Clinical Operations and Development Market, By Indication
    • 8.4.9 Australia Clinical Operations and Development Market
      • 8.4.9.1 Australia Clinical Operations and Development Market, By Phase
      • 8.4.9.2 Australia Clinical Operations and Development Market, By Service Type
      • 8.4.9.3 Australia Clinical Operations and Development Market, By Indication
    • 8.4.10 Rest of Asia Pacific Clinical Operations and Development Market
      • 8.4.10.1 Rest of Asia Pacific Clinical Operations and Development Market, By Phase
      • 8.4.10.2 Rest of Asia Pacific Clinical Operations and Development Market, By Service Type
      • 8.4.10.3 Rest of Asia Pacific Clinical Operations and Development Market, By Indication
  • 8.5 Latin America Clinical Operations and Development Market
    • 8.5.1 Latin America Clinical Operations and Development Market, By Country
    • 8.5.2 Latin America Clinical Operations and Development Market, By Phase
    • 8.5.3 Latin America Clinical Operations and Development Market, By Service Type
    • 8.5.4 Latin America Clinical Operations and Development Market, By Indication
    • 8.5.5 Brazil Clinical Operations and Development Market
      • 8.5.5.1 Brazil Clinical Operations and Development Market, By Phase
      • 8.5.5.2 Brazil Clinical Operations and Development Market, By Service Type
      • 8.5.5.3 Brazil Clinical Operations and Development Market, By Indication
    • 8.5.6 Mexico Clinical Operations and Development Market
      • 8.5.6.1 Mexico Clinical Operations and Development Market, By Phase
      • 8.5.6.2 Mexico Clinical Operations and Development Market, By Service Type
      • 8.5.6.3 Mexico Clinical Operations and Development Market, By Indication
    • 8.5.7 Argentina Clinical Operations and Development Market
      • 8.5.7.1 Argentina Clinical Operations and Development Market, By Phase
      • 8.5.7.2 Argentina Clinical Operations and Development Market, By Service Type
      • 8.5.7.3 Argentina Clinical Operations and Development Market, By Indication
    • 8.5.8 Rest of Latin America Clinical Operations and Development Market
      • 8.5.8.1 Rest of Latin America Clinical Operations and Development Market, By Phase
      • 8.5.8.2 Rest of Latin America Clinical Operations and Development Market, By Service Type
      • 8.5.8.3 Rest of Latin America Clinical Operations and Development Market, By Indication
  • 8.6 Middle East and Africa Clinical Operations and Development Market
    • 8.6.1 Middle East and Africa Clinical Operations and Development Market, By Country
    • 8.6.2 Middle East and Africa Clinical Operations and Development Market, By Phase
    • 8.6.3 Middle East and Africa Clinical Operations and Development Market, By Service Type
    • 8.6.4 Middle East and Africa Clinical Operations and Development Market, By Indication
    • 8.6.5 UAE Clinical Operations and Development Market
      • 8.6.5.1 UAE Clinical Operations and Development Market, By Phase
      • 8.6.5.2 UAE Clinical Operations and Development Market, By Service Type
      • 8.6.5.3 UAE Clinical Operations and Development Market, By Indication
    • 8.6.6 Israel Clinical Operations and Development Market
      • 8.6.6.1 Israel Clinical Operations and Development Market, By Phase
      • 8.6.6.2 Israel Clinical Operations and Development Market, By Service Type
      • 8.6.6.3 Israel Clinical Operations and Development Market, By Indication
    • 8.6.7 Saudi Arabia Clinical Operations and Development Market
      • 8.6.7.1 Saudi Arabia Clinical Operations and Development Market, By Phase
      • 8.6.7.2 Saudi Arabia Clinical Operations and Development Market, By Service Type
      • 8.6.7.3 Saudi Arabia Clinical Operations and Development Market, By Indication
    • 8.6.8 South Africa Clinical Operations and Development Market
      • 8.6.8.1 South Africa Clinical Operations and Development Market, By Phase
      • 8.6.8.2 South Africa Clinical Operations and Development Market, By Service Type
      • 8.6.8.3 South Africa Clinical Operations and Development Market, By Indication
    • 8.6.9 Rest of Middle East & Africa Clinical Operations and Development Market
      • 8.6.9.1 Rest of Middle East & Africa Clinical Operations and Development Market, By Phase
      • 8.6.9.2 Rest of Middle East & Africa Clinical Operations and Development Market, By Service Type
      • 8.6.9.3 Rest of Middle East & Africa Clinical Operations and Development Market, By Indication

Chapter 9. Competitive Landscape

  • 9.1 Key Market Players: Categorization
  • 9.2 Strategy Framework
  • 9.3 Vendor Landscape
  • 9.4 Strategies Categorization
    • 9.4.1 Launch/ Expansion/ Investment
    • 9.4.2 Partnership/ Collaboration/ Acquisition

Chapter 10. Company Profiles

  • 10.1 ClinChoice
    • 10.1.1 Business Overview
    • 10.1.2 Service Benchmarking
    • 10.1.3 Recent Developments
  • 10.2 Thermo Fisher Scientific Inc. (PPD Inc.)
    • 10.2.1 Business Overview
    • 10.2.2 Financial Snapshot
      • 10.2.2.1 Revenue by Segment
      • 10.2.2.2 Revenue by Region
    • 10.2.3 Service Benchmarking
    • 10.2.4 Recent Developments
  • 10.3 IQVIA
    • 10.3.1 Business Overview
    • 10.3.2 Financial Snapshot
      • 10.3.2.1 Revenue by Market Segment
      • 10.3.2.2 Revenue by Region
    • 10.3.3 Service Benchmarking
    • 10.3.4 Recent Developments
  • 10.4 Charles River Laboratories
    • 10.4.1 Business Overview
    • 10.4.2 Financial Snapshot
      • 10.4.2.1 Revenue by Market Segment
      • 10.4.2.2 Revenue by Region
    • 10.4.3 Service Benchmarking
    • 10.4.4 Recent Developments
  • 10.5 Syneos Health
    • 10.5.1 Business Overview
    • 10.5.2 Service Benchmarking
    • 10.5.3 Recent Developments
  • 10.6 Eli Lilly and Company
    • 10.6.1 Business Overview
    • 10.6.2 Financial Snapshot
      • 10.6.2.1 Revenue by Market Segment
      • 10.6.2.2 Revenue by Region
    • 10.6.3 Service Benchmarking
    • 10.6.4 Recent Developments
  • 10.7 Pfizer Inc.
    • 10.7.1 Business Overview
    • 10.7.2 Financial Snapshot
      • 10.7.2.1 Revenue by Market Segment
    • 10.7.3 Service Benchmarking
    • 10.7.4 Recent Developments
  • 10.8 Novo Nordisk A/S
    • 10.8.1 Business Overview
    • 10.8.2 Financial Snapshot
      • 10.8.2.1 Revenue by Market Segment
      • 10.8.2.2 Revenue by Region
    • 10.8.3 Service Benchmarking
    • 10.8.4 Recent Developments
  • 10.9 Parexel International (MA) Corporation
    • 10.9.1 Business Overview
    • 10.9.2 Service Benchmarking
    • 10.9.3 Recent Developments
  • 10.10 Caidya
    • 10.10.1 Business Overview
    • 10.10.2 Service Benchmarking
    • 10.10.3 Recent Developments